LEISHMANIASIS
(
SEVAMED 2002)
(Diagnosis,
Diagnostics, Immunodiagnosis, Immunodiagnostics, Pathogenesis, Vaccines & Drugs)
3309. Enserink M. Infectious diseases. Sand fly saliva may be key to new vaccine. Science. 293(5532):1028, 2001 Aug 10.
3310. Ghosh A. Labrecque S. Matlashewski G. Protection against Leishmania donovani infection by DNA vaccination: increased DNA vaccination efficiency through inhibiting the cellular p53 response. Vaccine. 19(23-24):3169-78, 2001 Apr 30.
3311. Handman E. Leishmania virulence: it's a knock out!. Trends in Parasitology. 17(2):60, 2001 Feb.
3312. Handman E. Leishmaniasis: current status of vaccine development. [Review] [157 refs] Clinical Microbiology Reviews. 14(2):229-43, 2001 Apr.
3313. Karkip, Parija S C, Koirala S. LD body-negative bone marrow cases of Kala-azar in Dharan, Nepal. J Commun Dis. 31(4): 261-2,1999.
3314. Kumar PV. Moosavi A. Karimi M. Safaei A. Noorani H. Abdollahi B. Bedayat GR. Subclassification of localized Leishmania lymphadenitis in fine needle aspiration smears. Acta Cytologica. 45(4):547-54, 2001 Jul-Aug.
3315. Martin-Sanchez J. Lopez-Lopez MC. Acedo-Sanchez C. Castro-Fajardo JJ. Pineda JA. Morillas-Marquez F. Diagnosis of infections with Leishmania infantum using PCR-ELISA. Parasitology. 122(Pt 6):607-15, 2001 Jun.
3316. Moore E. O'Flaherty D. Heuvelmans H. Seaman J. Veeken H. de Wit S. Davidson RN. Comparison of generic and proprietary sodium stibogluconate for the treatment of visceral leishmaniasis in Kenya. Bulletin of the World Health Organization. 79(5):388-93, 2001.
3317. Rajasekariah GH. Ryan JR. Hillier SR. Yi LP. Stiteler JM. Cui L. Smithyman AM. Martin SK. Optimisation of an ELISA for the serodiagnosis of visceral leishmaniasis using in vitro derived promastigote antigens. Journal of Immunological Methods. 252(1-2):105-19, 2001 Jun 1.
3318. Rathi S. Post-kala-azar dermal leishmaniasis with an atypical presentation. Journal of Dermatology. 28(6):341-2, 2001 Jun.
3319. Roberts L J, Handman E. Leishmaniasis. Br med J- South Asia Edn. 16(11): 853-6:2001.
3320. Romero GA. Guerra MV. Paes MG. Cupolillo E. Bentin Toaldo C. Macedo VO. Fernandes O. Sensitivity of the polymerase chain reaction for the diagnosis of cutaneous leishmaniasis due to Leishmania (Viannia) guyanensis. Acta Tropica. 79(3):225-9, 2001 Jun 22.
3321. Sharma M C, Bimal S, Ranjan A, Das V N R, Gupta A K, Kumar N, Kar S K. Relevance of direct agglutination test in seroepidemiological survey of kala-azar in epidemic foci of Bihar. J Commum Dis. 32(2): 117-22,2000.
3322. Sotiropoulos G. Wilbur B. Two cases of cutaneous Leishmaniasis presenting to the emergency department as chronic ulcers. Journal of Emergency Medicine. 20(4):353-6, 2001 May.
3323. Yaggi HK. Federman DG. Cutaneous leishmaniasis in an Italian woman: case report. Connecticut Medicine. 65(6):333-7, 2001 Jun.
3324. Zijlstra EE. el-Hassan AM. Leishmaniasis in Sudan. Post kala-azar dermal leishmaniasis. Transactions of the Royal Society of Tropical Medicine & Hygiene. 95 Suppl 1:S59-76, 2001 Apr.
Apr
02
4101.
Arevalo I, Ward B, Miller R, Meng TC, Najar E, Alvarez E, Matlashewski G,
Llanos-Cuentas A. Successful treatment of drug-resistant cutaneous leishmaniasis
in humans by use of imiquimod, an immunomodulator. Clin Infect Dis
2001 Dec 1;33(11):1847-51
4102.
Bourreau E, Prevot G, Gardon J, Pradinaud R, Launois P. High
intralesional interleukin-10 messenger RNA expression in localized cutaneous
leishmaniasis is associated with unresponsiveness to treatment. J Infect Dis
2001 Dec 15;184(12):1628-30
4103.
Bretsche PA, Ismail N, Menon JN, Power CA, Uzonna J, Wei G. Vaccination
against and treatment of tuberculosis, the leishmaniases and AIDS: perspectives
from basic immunology and immunity to chronic intracellular infections. Cell Mol
Life Sci 2001 Nov;58(12-13):1879-96
4104.
Dietze R, Carvalho SF, Valli LC, Berman J, Brewer T, Milhous W, Sanchez
J, Schuster B, Grogl M. Phase 2 trial of WR6026, an orally administered
8-aminoquinoline, in the treatment of visceral leishmaniasis caused by
Leishmania chagasi. Am J Trop Med Hyg 2001
Dec;65(6):685-9
4105.
Habibi GR, Khamesipour A, McMaster WR, Mahboudi F. Cytokine gene
expression in healing and non-healing cases of cutaneous leishmaniasis in
response to in vitro stimulation with recombinant gp63 using semi quantitative
RT-PCR. Scand J Immunol 2001
Oct;54(4):414-20
4106.
Lopez-Rios F, Gonzalez-Lois C, Sotelo T. Pathologic quiz case: a patient
with acquired immunodeficiency syndrome and endobronchial lesions. Arch Pathol
Lab Med 2001 Nov;125(11):1511-2
4107.
Mallik MK, Das DK, Haji BE. Fine needle aspiration cytology diagnosis of
cutaneous leishmaniasis in a 6-month-old child: a case report. Acta Cytol
2001 Nov-Dec;45(6):1005-7
4108.
Ouellette M. Biochemical and molecular mechanisms of drug resistance in
parasites. Trop Med Int Health 2001
Nov;6(11):874-82
4109.
Perez-Casas C, Herranz E, Ford N. Pricing of drugs and donations: options
for sustainable equity pricing. Trop Med Int Health 2001 Nov;6(11):960-4
4110.
Salotra P, Sreenivas G, Ramesh V, Sundar S. A simple and sensitive test
for field diagnosis of post kala-azar dermal leishmaniasis. Br J Dermatol
2001 Oct;145(4):630-2
4111.
Wortmann G, Sweeney C, Houng HS, Aronson N, Stiteler J, Jackson J,
Ockenhouse C. Rapid diagnosis of leishmaniasis by fluorogenic polymerase chain
reaction. Am J Trop Med Hyg 2001
Nov;65(5):583-7
July
02
4689.
Alrajhi AA, Ibrahim EA, De Vol EB, Khairat M, Faris RM, Maguire JH.
Fluconazole for the treatment of cutaneous leishmaniasis caused by
Leishmania major. N Engl J Med. 2002 Mar 21;346(12):891-5.
4690.
Katz KC, Walmsley SL, McLeod AG, Keystone JS, Detsky AS.
Clinical problem-solving. Where are you from? N Engl J Med. 2002 Mar
7;346(10):764-7.
4691.
Noyes H, Pratlong F, Chance M, Ellis J, Lanotte G, Dedet JP.
A previously unclassified trypanosomatid responsible for human cutaneous
lesions in Martinique (French West Indies) is the most divergent member of the
genus Leishmania ss. Parasitology. 2002 Jan;124(Pt 1):17-24.
4692.
Sabbatini M, Pisani A, Ragosta A, Gallo R, Borrelli F, Cianciaruso B.
Visceral Leishmaniasis in renal transplant recipients: is it still a challenge
to the nephrologist? Transplantation. 2002 Jan 27;73(2):299-301.
4693.
Sah SP, Sharma SK, Rani S. Kala
azar associated with malaria. Arch Pathol Lab Med. 2002 Mar;126(3):382-3.
4694.
Sousa-Atta ML, Salame GS, D'Oliveira A Jr, Almeida RP, Atta AM, Carvalho
EM. Immunoglobulin E antileishmanial antibody response in cutaneous
leishmaniasis. Clin Diagn Lab Immunol. 2002 Jan;9(1):101-4.
4695.
Verthelyi D, Kenney RT, Seder RA, Gam AA, Friedag B, Klinman DM. CpG
oligodeoxynucleotides as vaccine adjuvants in primates. J Immunol. 2002 Feb
15;168(4):1659-63.
Oct
02
5437. Anuja K. Recombinant fusion of functional regions of gp63 of leishmania with LTB of E. coli: expression, immunogenecity and efficacy to block steps important for leishmaniasis. Department of Chemistry, Gauhati University, Guwahati. 2001.
5438. Bourreau E, Prevot G, Gardon J, Pradinaud R, Hasagewa H, Milon G, Launois P. LACK-specific CD4(+) T cells that induce gamma interferon production in patients with localized cutaneous leishmaniasis during an early stage of infection. Infect Immun. 2002 Jun;70(6):3122-9.
5439.
Follador I, Araujo C, Bacellar O, Araujo CB, Carvalho LP, Almeida RP,
Carvalho EM. Epidemiologic and immunologic findings for the subclinical form of
Leishmania braziliensis infection. Clin Infect Dis 2002 Jun 1;34(11):E54-8
5440.
Hailu A. The use of direct agglutination test (DAT) in serological
diagnosis of Ethiopian cutaneous leishmaniasis. Diagn Microbiol Infect Dis
2002 Apr;42(4):251-6
5441.
Kafetzis DA, Maltezou HC. Visceral leishmaniasis in paediatrics. Curr
Opin Infect Dis. 2002 Jun;15(3):289-94. Review.
5442.
Machado P, Araujo C, Da Silva AT, Almeida RP, D'Oliveira Jr A,
Bittencourt A, Carvalho EM. Failure of early treatment of cutaneous
leishmaniasis in preventing the development of an ulcer. Clin Infect Dis. 2002
Jun 15;34(12):E69-73.
5443.
Morales MA, Cruz I, Rubio JM, Chicharro C, Canavate C, Laguna F, Alvar J.
Relapses versus reinfections in patients coinfected with Leishmania infantum and
human immunodeficiency virus type 1. J Infect Dis. 2002 May 15;185(10):1533-7.
5444.
Royer MA, Crowe CO. American cutaneous leishmaniasis. Arch Pathol Lab
Med. 2002 Apr;126(4):471-3.
5445.
Sahoo
B, Kaur I, Radotra BD, Kumar B. Cutaneous leishmaniasis in hilly areas of
Himachal Pradesh. J Dermatol. 2002 Apr;29(4):248-9.
Pathogenesis:
5446.
Cunningham AC. Parasitic adaptive mechanisms in infection by eishmania.
Exp Mol Pathol. 2002 Apr;72(2):132-41. Review.
Vaccines:
5447.
Campos-Neto A, Webb JR, Greeson K, Coler RN, Skeiky YA, Reed SG.
Vaccination with plasmid DNA encoding TSA/LmSTI1 leishmanial fusion proteins
confers protection against Leishmania major infection in susceptible BALB/c
mice. Infect Immun. 2002 Jun;70(6):2828-36.
|
|
|